|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
1.06/2.48
|
Enterprise Value
26.38B
|
Balance Sheet |
Book Value Per Share
28.72
|
Cash Flow |
Cash Flow Yield
0.17
|
Income Statement |
Total Revenue
19.34B
|
Operating Revenue Per Share
35.11
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourthsof sales, while the balance is generated from medical technology products that enable dialysis treatments. |